FAM71F2 Inhibitors
FAM71F2 inhibitors encompass a spectrum of chemical compounds designed to interfere with specific signaling pathways or biological processes that are essential for the functional activity of FAM71F2. Compounds like Staurosporine and Dasatinib are kinase inhibitors with broad targets, including those kinases whose phosphorylation cascades could be vital for FAM71F2's role in cellular signaling, potentially leading to a reduction in FAM71F2's activity when these cascades are inhibited. Similarly, the mTOR inhibitor Rapamycin could decrease FAM71F2's activity indirectly by disrupting the mTOR pathway, which is key for protein synthesis and cell growth regulation, processes that may be essential for FAM71F2 function. PI3K inhibitors, LY294002 and Wortmannin, also play a role by hindering the PI3K/Akt pathway, which could dampen the regulatory control over FAM71F2, assuming the protein's activity is contingent on this pathway's signals.
Furthermore, the MEK inhibitors PD98059 and U0126, the p38 MAPK inhibitor SB203580, and the Raf kinase inhibitor GW5074, are all designed to target intracellular signaling molecules upstream of potential regulatory points impacting FAM71F2. Inhibition ofthese pathways leads to a decrease in phosphorylation and activation of downstream effectors, which may, in turn, reduce FAM71F2 activity if it is interconnected with these routes. JNK inhibitor SP600125 targets stress-activated signaling pathways, which might attenuate FAM71F2 activity if it is responsive to cellular stress signals. The proteasome inhibitors Bortezomib and MG132 add another layer of regulation by preventing the degradation of ubiquitinated proteins, which could stall the turnover of proteins that modulate FAM71F2's stability or activity. In essence, these inhibitors collectively impose a multi-angled constraint on the operational pathways of FAM71F2, ensuring a comprehensive dampening of its functional activity within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that broadly targets multiple kinases, which can lead to the inhibition of downstream signaling pathways critical for protein functions, including those involving FAM71F2. Its inhibition of protein kinases can reduce phosphorylation events that might be essential for FAM71F2's role in signaling cascades. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that interferes with the mTOR signaling pathway. Since mTOR is crucial for protein synthesis and cell growth, its inhibition can lead to a decrease in the functional activity of proteins regulated by mTOR, potentially including FAM71F2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that prevents the phosphorylation and activation of PI3K-dependent signaling cascades, which could be involved in the regulation of FAM71F2 function or expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that prevents the activation of the MEK/ERK pathway, a pathway that could be implicated in the regulation of FAM71F2 activity, thus causing an indirect inhibition of FAM71F2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which by inhibiting p38 MAPK, can attenuate the cellular response to stress and cytokines, possibly affecting proteins like FAM71F2 that might be modulated by these stress-related pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that works similarly to PD98059, targeting the MEK1/2 kinases and potentially influencing the functional activity of proteins like FAM71F2 that are regulated by the ERK pathway. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a Raf kinase inhibitor, which by hindering Raf kinase can block the activation of downstream MEK/ERK signaling, potentially leading to decreased activity of FAM71F2 if it is involved in this signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which by inhibiting the JNK signaling pathway could influence proteins like FAM71F2 that may be regulated via stress-activated pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins and may affect the degradation of regulatory proteins involved in the control of FAM71F2 activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor similar to Bortezomib, which can indirectly influence FAM71F2 activity by altering the degradation of proteins that regulate FAM71F2 or its signaling pathways. | ||||||